Agency Forms Undergoing Paperwork Reduction Act Review, 3978 [E8-1017]

Download as PDF 3978 Federal Register / Vol. 73, No. 15 / Wednesday, January 23, 2008 / Notices Dated: January 10, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–1016 Filed 1–22–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–08–06AP] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Aerosol Generation by Cough— NEW—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Institute for Occupational Safety and Health (NIOSH) is authorized to conduct research to advance the health and safety of workers under Section 20(a)(1) of the 1970 Occupational Safety and Health Act. Many respiratory diseases are spread when healthy people come into contact with infectious fluids from sick individuals. The most common mode of transmission is direct contact with infected persons, or contact with items or people they have touched. In addition, however, some respiratory illnesses can also spread via infectious aerosols that are generated by coughing and sneezing. Riley et al. established that tuberculosis is spread by inhalation of respirable particles generated by infected individuals. British studies of classrooms and offices found aerosols containing viable salivary streptococci and other oral bacteria that were thought to be created during speaking, coughing, and sneezing. Severe acute respiratory syndrome (SARS) and avian influenza are known to spread through infectious aerosols, and this may include cough-generated aerosols as well. The airborne transmission of disease is of great concern to the public health community because of the increasing prevalence of drug-resistant strains of tuberculosis, the epidemic potential of newly-emerging diseases like avian influenza, and the threat of bioterrorism using agents such as bubonic plague. The purpose of this project is to better understand some of the factors involved in the production of aerosols of airway fluids by coughing. The project has two specific aims: Measure the quantity and size distribution of aerosol produced during human coughs and determine the effectiveness of surgical masks and N95 respirators at filtering coughgenerated aerosols. There is no cost to respondents other than their time. The total estimated annualized burden hours are 71. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Form All participants .................................... Qualified participants .......................... Pre-test questionnaire ...................................................... Health questionnaire ........................................................ Consent form .................................................................... Dated: January 10, 2008. Maryam Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–1017 Filed 1–22–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Number of respondents The meeting will be held February 14, 2008. The meeting time and location remains the same. The meeting is closed to the public. Dated: January 15, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 08–219 Filed 1–22–08; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health ebenthall on PROD1PC69 with NOTICES Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 13, 2008, 1 p.m. to February 13, 2008, 4:30 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on January 9, 2008, 73 FR 1634–1637. VerDate Aug<31>2005 15:17 Jan 22, 2008 Jkt 214001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 147 140 140 Number of responses per respondent Average burden per response (in hours) 1 1 1 5/60 5/60 20/60 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biology of Development and Aging Integrated Review Group, Cellular Mechanisms in Aging and Development Study Section. Date: February 5–6, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sir Francis Drake Hotel, Kimpton, 450 Powell Street, San Francisco, CA 94102. Contact Person: James P. Harwood, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of E:\FR\FM\23JAN1.SGM 23JAN1

Agencies

[Federal Register Volume 73, Number 15 (Wednesday, January 23, 2008)]
[Notices]
[Page 3978]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-1017]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-08-06AP]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Aerosol Generation by Cough--NEW--The National Institute for 
Occupational Safety and Health (NIOSH), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The National Institute for Occupational Safety and Health (NIOSH) 
is authorized to conduct research to advance the health and safety of 
workers under Section 20(a)(1) of the 1970 Occupational Safety and 
Health Act.
    Many respiratory diseases are spread when healthy people come into 
contact with infectious fluids from sick individuals. The most common 
mode of transmission is direct contact with infected persons, or 
contact with items or people they have touched. In addition, however, 
some respiratory illnesses can also spread via infectious aerosols that 
are generated by coughing and sneezing. Riley et al. established that 
tuberculosis is spread by inhalation of respirable particles generated 
by infected individuals. British studies of classrooms and offices 
found aerosols containing viable salivary streptococci and other oral 
bacteria that were thought to be created during speaking, coughing, and 
sneezing. Severe acute respiratory syndrome (SARS) and avian influenza 
are known to spread through infectious aerosols, and this may include 
cough-generated aerosols as well.
    The airborne transmission of disease is of great concern to the 
public health community because of the increasing prevalence of drug-
resistant strains of tuberculosis, the epidemic potential of newly-
emerging diseases like avian influenza, and the threat of bioterrorism 
using agents such as bubonic plague. The purpose of this project is to 
better understand some of the factors involved in the production of 
aerosols of airway fluids by coughing. The project has two specific 
aims: Measure the quantity and size distribution of aerosol produced 
during human coughs and determine the effectiveness of surgical masks 
and N95 respirators at filtering cough-generated aerosols.
    There is no cost to respondents other than their time. The total 
estimated annualized burden hours are 71.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                        Number of      Average
                                                                          Number of     responses    burden per
            Type of respondent                         Form              respondents       per      response (in
                                                                                       respondent      hours)
----------------------------------------------------------------------------------------------------------------
All participants.........................  Pre-test questionnaire.....           147             1          5/60
Qualified participants...................  Health questionnaire.......           140             1          5/60
                                           Consent form...............           140             1         20/60
----------------------------------------------------------------------------------------------------------------


    Dated: January 10, 2008.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E8-1017 Filed 1-22-08; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.